{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:18:31Z","timestamp":1769001511915,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.6061\/clinics\/2015(04)06","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T15:58:24Z","timestamp":1432655904000},"page":"250-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway"],"prefix":"10.1016","volume":"70","author":[{"given":"Mengguo","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.6061\/clinics\/2015(04)06_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2013.01.010","article-title":"Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies","volume":"31","author":"Fett","year":"2013","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.berh.2012.01.011","article-title":"Scleroderma - new aspects in pathogenesis and treatment","volume":"26","author":"Balbir-Gurman","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.autrev.2010.09.008","article-title":"Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis","volume":"10","author":"Galluccio","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2 Suppl 76","key":"10.6061\/clinics\/2015(04)06_bib4","first-page":"103","article-title":"Nailfold capillaroscopy abnormalities as predictors of mortality in patients with systemic sclerosis","volume":"31","author":"Kayser","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.6061\/clinics\/2015(04)06_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00393-004-0671-7","article-title":"Vascular changes in the pathogenesis of systemic sclerosis","volume":"63","author":"Distler","year":"2004","journal-title":"Z Rheumatol"},{"issue":"6","key":"10.6061\/clinics\/2015(04)06_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.6061\/clinics\/2015(04)06_bib7","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signalling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J Immunol"},{"issue":"4","key":"10.6061\/clinics\/2015(04)06_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1684\/ecn.2013.0325","article-title":"T cell abnormalities in systemic sclerosis with a focus on Th17 cells","volume":"23","author":"Brembilla","year":"2012","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib9","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.6061\/clinics\/2015(04)06_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A Induces Endothelial Inflammation in Systemic Sclerosis via the ERK Signalling Pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.trsl.2007.11.005","article-title":"Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis","volume":"151","author":"Gao","year":"2008","journal-title":"Transl Res"},{"issue":"4","key":"10.6061\/clinics\/2015(04)06_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1159\/000341462","article-title":"Tanshinone IIA improves miR-133 expression through MAPK ERK1\/2 pathway in hypoxic cardiac myocytes","volume":"30","author":"Zhang","year":"2012","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"10.6061\/clinics\/2015(04)06_bib13","first-page":"465","article-title":"Clinical and laboratory studies of the effect of an antilupus pill on systemic lupus erythematosus","volume":"9","author":"Wang","year":"1989","journal-title":"Zhong Xi Yi Jie He Za Zhi"},{"issue":"34","key":"10.6061\/clinics\/2015(04)06_bib14","first-page":"2426","article-title":"Inhibition effects of constituents of Radix Salviae Miltiorrhizae on proliferation and procollagen transcription of dermal fibroblasts in systemic sclerosis","volume":"87","author":"Lu","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"5","key":"10.6061\/clinics\/2015(04)06_bib15","first-page":"674","article-title":"Effects of danshen injection on the proliferation of rheumatoid arthritis fibroblast-like synoviocytes cultured with human serum","volume":"33","author":"Liu","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"10.6061\/clinics\/2015(04)06_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/132912","article-title":"Cardiovascular Protective Effects of Adjunctive Alternative Medicine (Salvia miltiorrhiza and Pueraria lobata) in High-Risk Hypertension","volume":"2013","author":"Woo","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2-3","key":"10.6061\/clinics\/2015(04)06_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejphar.2011.10.040","article-title":"Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress","volume":"674","author":"Chen","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056774","article-title":"Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt\/Skp2\/p27-associated pathway","volume":"8","author":"Luo","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jep.2005.01.057","article-title":"Tanshinone: an inhibitor of proliferation of vascular smooth muscle cells","volume":"99","author":"Wang","year":"2005","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jcb.21599","article-title":"Tanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signalling pathway","volume":"104","author":"Jin","year":"2008","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib21","first-page":"188","article-title":"Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit","volume":"39","author":"Zhang","year":"2008","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"17","key":"10.6061\/clinics\/2015(04)06_bib22","first-page":"2146","article-title":"Inhibitory effects and mechanism of tanshinone IIA on proliferation of rat aortic smooth muscle cells","volume":"33","author":"Li","year":"2008","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jep.2010.03.021","article-title":"Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signalling pathway","volume":"129","author":"Li","year":"2010","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.6061\/clinics\/2015(04)06_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094957","article-title":"Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.6061\/clinics\/2015(04)06_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jep.2009.07.020","article-title":"Effects of sodium tanshinone IIA sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro","volume":"125","author":"Huang","year":"2009","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"10.6061\/clinics\/2015(04)06_bib26","first-page":"581","article-title":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.6061\/clinics\/2015(04)06_bib27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.60.6.592","article-title":"European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes","volume":"60","author":"Valentini","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib28","first-page":"22","article-title":"Effects of Salvia Miltiorrhiza Bunge on the Proliferation and Collagen Synthesis in Systemic Scleroderma Skin Fibroblasts","volume":"31","author":"Li","year":"1998","journal-title":"Chinese Journal of Dermatology"},{"issue":"1","key":"10.6061\/clinics\/2015(04)06_bib29","first-page":"47","article-title":"Effects of Salvia Miltiorrhiza Bunge on the collagen gene expression in Systemic Scleroderma Skin Fibroblasts","volume":"32","author":"Li","year":"1999","journal-title":"Chinese Journal of Dermatology"},{"issue":"10","key":"10.6061\/clinics\/2015(04)06_bib30","first-page":"693","article-title":"Transcriptional regulation of type I procollagen gene in scleroderma-derived high collagen-producing fibroblast clones by Radix Salviae Miltiorrhizae","volume":"44","author":"Zhu","year":"2011","journal-title":"Chinese Journal of Dermatology"},{"issue":"1-3","key":"10.6061\/clinics\/2015(04)06_bib31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2007.04.031","article-title":"Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis","volume":"568","author":"Fu","year":"2007","journal-title":"Eur J Pharmacol"},{"issue":"11-12","key":"10.6061\/clinics\/2015(04)06_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.lfs.2008.07.011","article-title":"Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest","volume":"83","author":"Zhou","year":"2008","journal-title":"Life Sci"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/CAD.0b013e32834e5592","article-title":"Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro","volume":"23","author":"Zhang","year":"2012","journal-title":"Anticancer Drugs"},{"issue":"11","key":"10.6061\/clinics\/2015(04)06_bib34","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1248\/bpb.33.1828","article-title":"Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase\/AKT pathway","volume":"33","author":"Won","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.6061\/clinics\/2015(04)06_bib35","article-title":"Tanshinone IIA Inhibits Growth of Keratinocytes through Cell Cycle Arrest and Apoptosis: Underlying Treatment Mechanism of Psoriasis","volume":"2012","author":"Li","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"10.6061\/clinics\/2015(04)06_bib36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/aps.2010.176","article-title":"Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes","volume":"31","author":"Hong","year":"2010","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2013.2913","article-title":"Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo","volume":"27","author":"Chen","year":"2012","journal-title":"Oncol Rep"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1142\/S0192415X11008890","article-title":"Tanshinone IIA inhibits angiotensin II-induced cell proliferation in rat cardiac fibroblasts","volume":"39","author":"Chan","year":"2011","journal-title":"Am J Chin Med"},{"issue":"4","key":"10.6061\/clinics\/2015(04)06_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/emm.1999.28","article-title":"Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3","volume":"31","author":"Sung","year":"1999","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.6061\/clinics\/2015(04)06_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000362997","article-title":"MCP-1 Stimulates MMP-9 Expression via ERK 1\/2 and p38 MAPK Signalling Pathways in Human Aortic Smooth Muscle Cells","volume":"34","author":"Yang","year":"2014","journal-title":"Cell Physiol Biochem"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222013953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-70-4\/cln-70-04-250.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:03:02Z","timestamp":1761721382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222013953"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322015000400250&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4418395\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1807593222013953"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2015(04)06","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2015(04)06","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}